DEF 14A: Finnovate Acquisition Corp. Seeks Shareholder Approval for Extension to Complete Business Combination

Finnovate Acquisition Corp. is seeking shareholder approval to extend the deadline for completing a business combination from May 8, 2024, to November 8, 2024.

Summary

• Finnovate Acquisition Corp. is holding an extraordinary general meeting on May 2, 2024, to seek shareholder approval for several proposals.
• The primary proposal is to extend the date by which the company must complete a business combination from May 8, 2024, to November 8, 2024, or an earlier date determined by the board.
• This extension is needed to complete the proposed business combination with Scage Future.
• Shareholders will also vote to ratify the selection of Marcum LLP as the company's independent auditor for the year ending December 31, 2024.
• Additionally, shareholders will vote on a proposal to allow the meeting to be adjourned if necessary to solicit additional proxies.
• If the extension is approved, the Sponsor will contribute loans of the lesser of $37,500 or $0.025 per non-redeemed public share each month until November 8, 2024.
• The company estimates the per-share pro rata portion of the Trust Account will be approximately $10.92 at the time of the Meeting.
• The closing price of the company's ordinary shares on April 12, 2024, was $11.27.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While the extension provides more time, it also introduces uncertainty and potential dilution. The outcome depends on whether the business combination with Scage is successful.

Positives

• The proposed extension provides additional time to complete the business combination with Scage Future, potentially benefiting shareholders.
• If the extension is approved, the Sponsor will contribute loans to the Trust Account, increasing the per-share value.
• Shareholders retain the right to redeem their Public Shares regardless of their vote on the extension proposal.
• The Board believes shareholders will benefit from the Company consummating an initial business combination and is proposing the Articles Extension to extend the date by which the Company may complete an initial business combination.

Negatives

• If the extension is not approved, the company will be forced to liquidate, and the warrants will expire worthless.
• Redemptions in connection with the extension vote could leave the company with insufficient cash to complete a business combination.
• The Sponsor and directors have interests in the proposals that may conflict with those of other shareholders.
• The amount remaining in the Trust Account may be significantly reduced from the approximate $52,130,893 that was in the Trust Account as of April 12, 2024.

Risks

• The company may not be able to complete a business combination by the expiration of the Articles Extension, even if the Articles Extension Proposal is approved by our shareholders, in which case, to the extent we do not obtain any further extension, we would cease all operations except for the purpose of winding up and we would redeem our Public Shares and liquidate and dissolve.
• The fact that we will have separate redemption periods in connection with the Articles Extension and an initial business combination vote could exacerbate these risks.
• Additional extensions beyond the Articles Extension may be required, which may subject us and our shareholders to additional risks and contingencies that would make it more challenging for us to complete an initial business combination.
• If Nasdaq delists our securities from trading on its exchange and we are not able to list our securities on another national securities exchange, we expect our securities could be quoted on an over-the-counter market.
• Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations.
• If we are deemed to be an investment company under the Investment Company Act, we may be required to institute burdensome compliance requirements and our activities may be restricted, which may make it difficult for us to complete our initial Business Combination.
• We may not be able to complete an initial business combination with certain potential target companies if a proposed transaction with the target company may be subject to review or approval by regulatory authorities pursuant to certain U.S. or foreign laws or regulations.

Future Outlook

The company intends to hold another shareholders meeting prior to the expiration of the Articles Extension in order to seek shareholder approval of our initial business combination with Scage.

Management Comments

• The Board has determined that it is in the best interests of the Company and its shareholders to extend the date by which the Company has to consummate an initial business combination to the Articles Extension Date in order for our shareholders to have the opportunity to participate in an investment in the combined company.
• After careful consideration of all relevant factors, the Board has determined that each of the proposals is advisable and recommends that you vote or give instruction to vote FOR such proposals.

Industry Context

This announcement is typical for SPACs approaching their deadline to complete a business combination, as they often seek extensions to finalize deals.

Comparison to Industry Standards

• Seeking extensions is a common practice among SPACs facing deadlines to complete business combinations.
• The terms of the Sponsor's contribution to the trust account are within the typical range observed in similar extension proposals.
• Comparable companies that have sought extensions include Digital World Acquisition Corp. and CF Acquisition Corp. VI.

Management Changes

Related Party Transactions

• The Sponsor purchased an aggregate of 8,243,038 private placement warrants for an aggregate amount of $8,243,038 simultaneously with the consummation of the IPO.
• Since November 2021, we have paid the Sponsor a total of $3,000 per month for office space, utilities and secretarial and administrative support services.
• The Sponsor has made outstanding loans to the Company in the aggregate amount of approximately $1,743,136 as of April 12, 2024 (which consists of approximately $1,000,000 outstanding under the June 2023 Promissory Note and $743,136 in working capital advances).

Stakeholder Impact

• Shareholders have the opportunity to vote on the extension and redeem their shares.
• Employees may be impacted depending on the outcome of the business combination.
• The business combination with Scage Future could impact customers and suppliers of both companies.

Next Steps

• Shareholders will vote on the proposals at the extraordinary general meeting on May 2, 2024.
• If the extension is approved, the company will continue to work towards completing the business combination with Scage Future.
• The company intends to hold another shareholders meeting prior to the expiration of the Articles Extension in order to seek shareholder approval of our initial business combination with Scage.

Key Dates

Keywords

business combination, articles extension, redemption rights, proxy statement, finnovate acquisition corp, scage future, shareholder vote, trust account, sponsor loans, auditor ratification